Alkermes’ Pops Lays Out Novel Drug Vision For Year Ahead

 
• By Mandy Jackson
Richard Pops, CEO of Alkermes
Alkermes CEO Richard Pops is focused on novel drugs going forward • Source: Alkermes PLC

More from Strategy

More from Business